Loading clinical trials...
Loading clinical trials...
This is an intermediate-size expanded access program (EAP) study. The purpose of this EAP is to provide continued access to LP352, an investigational drug product being investigated in participants wi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Longboard Pharmaceuticals
NCT06872125 · Dravet Syndrome
NCT05419492 · Dravet Syndrome
NCT05066217 · Lennox Gastaut Syndrome
NCT04462770 · Dravet Syndrome
NCT06401538 · Absence Epilepsy, Jeavons Syndrome, and more
Rancho Research Institute
Downey, California
University of California Los Angeles (UCLA)
Los Angeles, California
University of California Benioff Childrens Hospital
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions